1080030P
The Director, Biosimilar Business Development shapes and advances the company's biosimilars growth strategy by identifying, evaluating, negotiating, and executing business development opportunities. This role leads the assessment and execution of in-licensing, co-development, commercialization, acquisition, and strategic partnership opportunities to expand the biosimilars portfolio globally. The position involves leading due diligence, transaction execution, and maintaining strategic partnerships across the pharmaceutical and biotechnology industries.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1080030P.
1080030P didn’t post a salary, so this is our estimate from similar listings.
Director, Biosimilar Business Development
Teva Pharmaceutical
Director, Biosimilar Business Development
Teva Pharmaceutical
Transaction Advisory Services Manager
weaver levi llc
Transaction Advisory Services Manager
weaver levi llc
Transaction Advisory Services Manager
Weaver Consultants Group
Transaction Advisory Services Manager
Weaver Consultants Group